Mesotherapy before and after care: the first 7 days

Published: 1 October 2026 9 min read Dr. Shimaa Fouad

Medically reviewed by: Dr. Alyaa Said Abu Taleb

This article was translated into English from the Arabic original and reviewed for medical accuracy.

Article illustration: Mesotherapy before and after care: the first 7 days

Before-and-after care starts with knowing what will be injected

“Mesotherapy” is not the name of one substance or one standardized treatment plan. It may describe superficial injections using different formulations, aims and anatomical sites, so one aftercare sheet cannot fit every patient. Before the appointment, identify the product, active ingredient, concentration and proposed site, and establish whether the product was manufactured for injection. The US Food and Drug Administration has warned that unapproved fat-dissolving products have been associated with infection, scarring, skin changes and painful nodules. The strongest available evidence instead concerns a particular deoxycholic-acid product used in a defined area beneath the chin, not every “cocktail” or body site [1, 2, 9].

This article does not decide whether mesotherapy suits your goal, and it does not repeat a complete complication catalogue. It provides a practical route from before the needle through day seven. If your question is about overall safety, read Is mesotherapy safe? first. If the proposed procedure is a fat-dissolving injection, the linked side-effects guide examines those risks in more detail. In every case, written instructions from the treating clinician for the actual substance and site take priority over generic advice found online [1, 4, 7].

Before the session: review medicines, allergies and the skin

Prepare a complete list of every medicine and supplement you take, even when it seems unrelated to the skin. Disclose anticoagulants, antiplatelet medicines, bleeding disorders, easy bruising, previous allergies, and any reaction to an injection or local anaesthetic. The approved deoxycholic-acid label calls for caution when excessive bleeding is present or antiplatelet or anticoagulant treatment is used, because local bleeding and bruising may increase. That means “ask your doctor,” not “stop the medicine.” Never stop prescribed aspirin or an anticoagulant independently; interruption may create a more important risk than bruising, and the treating clinician and prescriber should determine the plan [2, 7].

Inspect the intended site in good light before the appointment. Infection, an open wound, discharge, an inflamed rash or infected spots should prompt contact with the clinician before attendance; infection at the injection site is a stated contraindication in the deoxycholic-acid label [2]. Also disclose earlier procedures or surgery that changed local anatomy, and previous swallowing difficulty when treatment is near the chin or neck. This is not a paperwork exercise. It helps the clinician decide whether the session should proceed, be postponed or be changed for the actual product, site and individual [2, 7].

Before any injection, ask to see the original vial and note the product, ingredients, concentration, manufacturer, lot number and expiry date. Ask whether use at the proposed site is authorized or studied, who will perform the injections, and what training that person has in local anatomy and complication management. Informed consent means understanding the realistic benefit, evidence limits, alternatives including no procedure, expected reactions, important complications and the route for post-treatment contact. The American Society of Plastic Surgeons policy on mesotherapy and injection lipolysis emphasized limited data and non-standardized formulations, so the session name alone is not adequate for consent [4, 7].

Agree on a specific follow-up plan before treatment starts. Who responds if a problem develops at night or on a non-working day? Is a review planned? Which signs require a photograph and message, same-day examination, or emergency care? Request written instructions that name the substance and site rather than a vague generic sheet. Do not accept a promise of no swelling or bruising, or a guaranteed result. Deoxycholic-acid studies recorded more local reactions than placebo injections despite efficacy in selected patients [9, 10]. Take time to decide; if answers remain unclear or the vial cannot be identified, postponement is reasonable [1, 4]. If the product offered is mesopeptide, review the mesopeptide ingredients and what each one does.

Session day: what should happen during preparation and injection?

At the start of the session, the clinician should check whether anything has changed since assessment: a new medicine, allergy, infection, fever, wound or procedure in the area. The site and plan should then be identified and explained before treatment begins. The Centers for Disease Control and Prevention describes safe injection practice as including hand hygiene, medication preparation in a clean area, aseptic technique, a new needle and syringe, and safe disposal. Single-dose vials must not be shared between patients, and used equipment must not re-enter a vial. These measures prevent transmission of infection; they are not optional cosmetic extras [3].

Stinging, pressure or discomfort may occur during injection, although the experience varies with the substance, site and anaesthetic approach. You should be able to report sudden, severe or unusual pain rather than assuming it must be endured. Afterwards, obtain a record of the product and lot, treatment date, injection sites and anything notable during the procedure. Before leaving, understand what is expected over the first hours, what is specifically permitted or restricted, and whom to contact. If massage, compresses or medication are advised, the direction should relate to the actual substance, site and patient; no single home-care instruction is valid for every form of mesotherapy [2, 3, 7].

From the end of treatment to 24 hours: create a comparison baseline

Once home, read the written instructions and keep the contact number accessible. Photograph the site in consistent light if the clinician agrees; the image is not a substitute for assessment, but it can show whether redness or swelling is expanding or settling. Local pain, tenderness, redness, swelling, bruising, numbness or firmness may follow some injections and were common reactions in studies of submental deoxycholic acid [2, 9, 10]. The presence of a symptom alone does not determine whether it is normal. The substance, site, severity and direction of change matter more.

Do not massage the area, squeeze a lump, apply an irritating home remedy, or inject another substance yourself. Follow only the clinician's instructions about washing, compresses, activity and medication. If advice about strenuous exercise, heat, sauna, sun or a skin product is absent, ask instead of guessing. Keep the site clean without scrubbing, and do not share towels or items that contact broken skin. Record when each symptom began and any medicine taken. Do not wait until the end of the day if pain is severe from the outset, the skin becomes strikingly pale, blue or dark, or the face or tongue swells rapidly [2, 6, 7].

Days 2–7: follow the trend, not one isolated appearance

On days two and three, compare pain, redness and swelling with the baseline. The aim is not to make every mark disappear by a fixed deadline; it is to understand the trend. A mild stable reaction with a clear plan differs from increasing pain, spreading redness, marked warmth, discharge or an enlarging lump. Cellulitis can present as painful, hot and swollen skin and commonly needs prompt treatment. Nontuberculous mycobacterial infection after mesotherapy may present later with multiple nodules or abscesses, sometimes without prominent systemic symptoms. A persistent or evolving skin lesion should therefore not be concealed with a cream or random antibiotic [5, 8].

From day four through day seven, review whether movement, texture and colour are improving in line with the instructions you received. Day seven is not a certificate of safety or a promise that every swelling must have disappeared; reactions vary by substance and site. It is, however, a useful point for contact when there is no clear improvement or when unexplained numbness, firmness or asymmetry persists. Send consistently lit images with a brief description of onset and direction of change, but do not rely on messaging when a sign is severe. Do not arrange another session or try to “break down” a lump with massage before its cause has been assessed [2, 7, 8].

Signs that need prompt contact or emergency care

Seek prompt medical assessment for severe or increasing pain, spreading redness or warmth, discharge, fever, an ulcer, blisters, marked colour change, or an enlarging lump. After injections near the chin, a newly uneven smile, weak lip movement or swallowing difficulty requires prompt contact because the deoxycholic-acid label lists nerve-branch injury and dysphagia among important risks [2]. Do not try to diagnose infection or tissue injury from a photograph alone, and do not begin treatment with leftover medicines at home; treatment depends on examination and cause [5, 7, 8].

Go to emergency care immediately for breathing difficulty, wheezing, rapid swelling of the tongue or throat, swallowing difficulty that prevents fluids, severe dizziness, collapse, confusion, or unusually blue, grey or pale lips or skin. These may indicate anaphylaxis and require urgent treatment [6]. If injection was near the eye and sudden blurred or reduced vision develops, do not wait for a reply to a message. Do not drive yourself when faint or severely weak. A useful rule is that a mild reaction improving according to plan can be monitored, while a severe, rapid or worsening sign needs faster escalation [2, 5, 6].

The next step: assessment and a written follow-up plan

If you are considering a session, prepare the proposed product name or a vial photograph when available, plus a list of medicines, supplements, allergies and previous procedures. State your goal in one sentence and ask whether the concern is genuinely superficial fat or instead loose skin or another cause. A sound assessment may lead to proceeding, postponement, a different option, or no procedure; all are legitimate outcomes. The decision should follow examination and clear information about the product and site, not a marketing name or before-and-after photograph [1, 4, 7].

The medical team at La Rose can discuss the situation individually at the Maadi and Fifth Settlement, New Cairo branches, without promising an outcome or assuming mesotherapy suits everyone. During the visit, request a written plan covering preparation, what to expect during the first week, how to make contact and when review is appropriate for the product and area. If you already have increasing pain, possible infection, skin colour change, swallowing difficulty, facial weakness or any emergency sign described above, seek the level of care appropriate to its severity instead of waiting for a routine cosmetic appointment. You can book a consultation with the medical team when you need a structured starting assessment [2, 5, 6].

Knowledge Centre

How this article was reviewed

This content is for health education and does not replace diagnosis or an individual care plan.

Author listed in record
Dr. Shimaa Fouad
Reviewer listed in record
Dr. Alyaa Said Abu Taleb
Linked medical sources
11
Publication and review history
  1. Published: 1 October 2026
  2. Last updated: 8 October 2026
  3. 1 October 2026: We reviewed the article and updated its information for 2026.
  4. 8 October 2026: Added a link to a related article so readers can find more detail; no change to the medical content.
  5. 8 October 2026: We clarified preparation and care before and after mesotherapy.
  6. Review record: A reviewer is listed in the publication record
  7. Linked medical sources: 11

Frequently asked questions

There is no universal restriction list for every formulation. The priorities are avoiding an unidentified product, not injecting through infection or a wound, and disclosing medicines, supplements, allergies and earlier procedures. Never stop prescribed medication independently. Ask for written instructions specific to the actual substance regarding skin products and activity before the appointment [1, 2, 7].

No. Do not independently stop prescribed aspirin, an antiplatelet medicine or an anticoagulant. Some injections may cause more local bruising or bleeding with these medicines, but interruption can create a greater risk. Tell both the procedural clinician and the prescriber; they should decide whether the appointment proceeds or is postponed without an unsupervised treatment change [2, 7].

The answer depends on the substance, site and condition of the skin, so follow the clinician's written sheet. Do not massage or squeeze a lump, and do not apply heat, a home mixture or an irritating cream independently. If the instructions do not clearly state when ordinary washing or strenuous exercise can resume, ask rather than applying generic advice to the wrong product [2, 7].

There is no single duration for every substance and body site. Swelling is common with submental deoxycholic acid, but evidence for that product cannot provide a deadline for every cocktail or area. Follow the trend: swelling that settles according to plan differs from swelling that expands or accompanies severe pain, redness, heat or colour change. Ask about the expected course for the specific product [2, 9, 10].

Spreading redness with warmth, increasing pain, swelling, discharge or fever needs prompt assessment. Some unusual infections may appear later as multiple nodules or abscesses without an obvious systemic fever. A consistent photograph can help comparison but cannot diagnose the cause. Do not use a random antibiotic; examination determines whether infection is present and what treatment is appropriate [5, 8].

Bring the product name, a vial photograph and lot number when available, the treatment date, injection sites, medicine list and allergies. Prepare serial photographs in similar lighting and note when the symptom began and whether it is worsening or settling. These details help the clinician, but they must not delay emergency care for breathing difficulty, rapid throat swelling, collapse or severe swallowing difficulty [2, 6, 7].

Related care

Written by

Dr. Shimaa Fouad

Dr. Shimaa Fouad

Physician, Clinical & Therapeutic Nutrition Specialist, ESPEN member

  • Physician; specialist in clinical and therapeutic nutrition and weight management
  • Member of the European Society for Clinical Nutrition and Metabolism (ESPEN)
  • Over 18 years of experience
  • Focus on insulin resistance, PCOS, hypothyroidism and metabolic disorders
  • Obesity alongside rheumatological and immune conditions; healthy weight gain

Dr. Shimaa Fouad is a physician specialising in clinical and therapeutic nutrition and weight management, and a member of the European Society for Clinical Nutrition and Metabolism (ESPEN), with more than 18 years of experience. She focuses on cases where standard diets have not worked, such as insulin resistance, polycystic ovary syndrome, hypothyroidism and metabolic disorders, and obesity alongside rheumatic and immune conditions, as well as underweight and healthy weight gain. Each plan is built on a full InBody analysis and a reading of the medical tests rather than a ready-made diet, with weekly follow-up and adjustments as progress is made.

View profile

You may also find helpful

Start with a real consultation - book now

Booking ahead is required. Patients are seen in order of arrival.